39 JRP.- INTERFERON BETA 1A MICROGRAMOS/0.5 ML. (EQUIVALENT TO 6 MILLION IU), INJECTABLE SOLUTION IN PRE-FILLED SYRINGE RFERON BETA.

This tender concerns the procurement of '39 JRP.- INTERFERON BETA 1A MICROGRAMOS/0.5 ML. (EQUIVALENT TO 6 MILLION IU), INJECTABLE SOLUTION IN PRE-FILLED SYRINGE RFERON BETA.' The contracting entity is the Hospital de Especialidades (Specialty Hospital). The procurement method is 'Compra Menor' (Minor Purchase), suggesting a simplified procedure for this acquisition. The tender status is 'Adjudicado' (Awarded), indicating that a contract has been finalized. A key instruction is that quotations must be sent to the Purchasing Department of the Specialty Hospital (I.H.S.S.), and they must be signed, sealed, and dated in a sealed envelope, clearly identifying the quotation number (CM-374-IHSS-HE-2023). This tender is for a specific pharmaceutical product, Interferon Beta 1a, in a pre-filled syringe format, likely for medical treatment purposes within the hospital.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Honduras, Latin America, this opportunity is open to firms and consortiums.

Published through ONCAE - Honduras, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.